跳至主要内容
临床试验/NCT02789293
NCT02789293已完成不适用

Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients

EyeTechCare7 个研究点 分布在 4 个国家目标入组 80 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
7
主要终点
Efficacy endpoint : Reduction of intraocular pressure

研究概览

简要总结

The purpose of the this study is to collect safety and efficacy data on Focused Ultrasound treatment (UCP procedure) in open angle glaucoma patients without previous glaucoma surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Open Angle Glaucoma patient (Primary Open Angle Glaucoma (POAG) including Pigmentary Glaucoma (PG) and PseudoExfoliative Glaucoma (PXF))
  • Any patients without previous conventional glaucoma surgery failure (trabeculectomy, Deep Sclerectomy, Ahmed valve, drainage device implantation, cyclo cryotherapy, Diode laser cyclo-destruction)
  • Subjects where the IOP is not adequately controlled with glaucoma medication, with IOP ≥ 21 mm Hg and <30 mmHg
  • No previous intraocular surgery or laser treatment during the 90 days before HIFU Day
  • Age > 18 years and < 90 years
  • Patient able and willing to complete postoperative follow-up requirements

排除标准

  • Patient who has been diagnosed for normal tension glaucoma
  • Ocular or retrobulbar tumor
  • Ocular infection within 14 days prior to the HIFU procedure
  • Ocular disease other than glaucoma that may affect assessment of visual acuity and/or IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy, proliferative diabetic retinopathy, clinically significant macular edema...)

结局指标

主要结局

Efficacy endpoint : Reduction of intraocular pressure

时间窗: 24 months

Reduction of intraocular pressure at 24 months relative to the preoperative value assessed at each follow-up visits with the final measurement of success at 24 months

次要结局

  • Efficacy Endpoint : Mean IOP variation (%)(24 months)
  • Safety : rate of per and post-operative complications/adverse effects(24 months)
  • Efficacy endpoint : Mean IOP (mmHg)(24 months)
  • Mean Number of ocular hypotensive medications(24 months)

研究者

发起方
EyeTechCare
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验